After peaking at 4,316,233 births in 2007, the birth rate in the United States fell 4 percent by 2009, and a provisional count in 2010 indicates the number is continuing to decline, according to a March data brief released by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.
One in 8 women and men are diagnosed with infertility. In honor of National Infertility Awareness Week, RESOLVE is busting myths and misconceptions about infertility. Click through the slideshow to learn more about these misconceptions and share some myths you've heard in our comments section.
Higher serum polychlorinated biphenyl (PCB) concentration levels that are within the normal range for women in the general U.S. population are associated with failed implantation in women undergoing in vitro fertilization (IVF), according to a study published online Feb. 24 in Environmental Health Perspectives.
The 2009 H1N1 pandemic caused anxiety and concern, especially for pregnant women and their physicians. The Centers for Disease Control (CDC) recognized this special patient population and the increased risk for serious problems and negative outcomes-both for the women and their unborn babies. As such, the CDC advised doctors to provide antiviral medicines to those with symptoms of the flu and vaccines to those pregnant women who were eligible. They further partnered with the American College of Obstetricians and Gynecology, the American Medical Association, and the American Academy of Family Physicians to educate clinicians and urge their participation in the 2009 H1N1 vaccination programs.
Is there a way to predict which patients will have the best outcomes following an assisted reproductive intervention? Dr William Gibbons, director of the Family Fertility Program at Texas Children’s Hospital and professor of obstetrics and gynecology at Baylor College of Medicine, and colleagues examined birth weight and gestational age of singleton pregnancies from in vitro fertilization, donor egg, and gestational carrier cycles to determine which factors most influence outcomes.
Progesterone support during the luteal phase is needed to allow for implementation in medically assisted cycles. To date, available options have not met all of the ideals of the “perfect” progesterone strategy-easy to administer, safe with minimal adverse effects, and effective in producing pregnancies.
The fertility field has seen incredible successes with in vitro fertilization and intracytoplasmic sperm injection. However, the resulting successes have yielded concern over the high rates of multiple pregnancies, which can result in increased maternal and perinatal morbidity and mortality as well as increased health care utilization and costs.
One serum blood test is sufficient to diagnose hyperprolactinemia, and dynamic testing of prolactin secretion should be avoided, according to new guidelines published in the February issue of the Journal of Clinical Endocrinology & Metabolism.
Emotional distress some women experience prior to undergoing fertility treatment appears to have no bearing on the likeihood that the treatment will result in a successful pregnancy, according to a literature analysis published Feb. 23 in BMJ.
I was recently asked by WebMD to comment on a newly published study that highlights a possible link between epilepsy, its treatment, and infertility, but a finding in the study has broader implications for all patients trying to conceive. First, a little about the study, and afterwards I will show how it applies to everyone trying to build a family.
Antioxidant supplementation in subfertile men may increase the likelihood of pregnancy and live births for couples undergoing assisted reproduction techniques, according to a review published online Jan. 19 in the Cochrane Database of Systemic Reviews
MONDAY, Jan. 17 (HealthDay News) -- Women with occupational exposure to phthalates or pesticides appear to have a higher risk of adverse fertility and pregnancy outcomes, including prolonged time to pregnancy (TTP) and lower birth weight, according to a study published online Dec. 20 in Occupational and Environmental Medicine.
Can HBA replace the use of SPA test in male partner screening before in vitro fertilization?
Hello, today we’re talking with Dr. Fleischman about urinary incontinence. This is Roberta Speyer of ObGyn.net, and I have the pleasure today to be talking to a specialist who deals with urinary incontinence in America.
Today we are going to talk about urinary incontinence and how OBGYN physicians can fit this into their practice. As a practicing OBGYN yourself, this is something you have a great degree of specialization in.
The symptoms of overactive bladder – urinary frequency, urgency, and urge incontinence – affect an estimated 1 in 11 adults of all ages in the United States.
More reproductive-age women with a diagnosis of cancer are receiving fertility preservation counseling from their doctors-but how many of those patients then decide to undergo fertility preservation? And how does their decision impact them later in life?
New research from the Eunice Kennedy Shriver National Institute for Child Health and Human Development confirms the need for H1N1 vaccines in women before undergoing infertility treatment.
NICHD, Endometriosis, and Female Infertility Research
From the Annual Conference of the European Society of Human Reproduction and Embryology in Rome
From the Annual Conference of the European Society of Human Reproduction and Embryology in Rome
From the Annual Conference of the European Society of Human Reproduction and Embryology in Rome
From the Annual Conference of the European Society of Human Reproduction and Embryology in Rome
Follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) represent the two most frequently utilized laboratory tests in determining ovarian reserve (OR). This study determined the clinical significance of their concordance and discordance in female infertility patients.
Over the past 12 years, it has become increasingly recognized that insulin resistance is central to the pathogenesis of the polycystic ovarian syndrome (PCOS). The use of insulin-sensitizing agents, such as Metformin, a biguanide insulin-lowering agent in ovulation induction for IVF, has been widely studied.
